Home > Annual Financials > BLISS GVS PHARMA

BLISS GVS PHARMA Financial Statement Analysis
[BOM: 506197|NSE : BLISSGVS]

The Revenues of BLISS GVS PHARMA have increased by 5.13% YoY .
The Earnings Per Share (EPS) of BLISS GVS PHARMA has increased by 52.63 % YoY.
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Last 5 Annual Financial Results
[BOM: 506197|NSE : BLISSGVS]

ConsolidatedMar2026
Mar2025
Mar2024
Mar2023
Mar2022
Revenues ₹810 Cr₹770 Cr₹752 Cr₹747 Cr₹577 Cr
Expenses ₹683 Cr₹620 Cr₹634 Cr₹629 Cr₹471 Cr
Operating Profit (Excl OI) ₹127 Cr₹151 Cr₹117 Cr₹118 Cr₹107 Cr
Other Income ₹36 Cr₹29 Cr₹18 Cr₹31 Cr₹22 Cr
Interest ₹8.12 Cr₹6.91 Cr₹10 Cr₹4.74 Cr₹7.24 Cr
Depreciation ₹29 Cr₹26 Cr₹19 Cr₹17 Cr₹17 Cr
Profit Before Tax ₹126 Cr₹117 Cr₹106 Cr₹54 Cr₹104 Cr
Profit After Tax ₹90 Cr₹82 Cr₹77 Cr₹23 Cr₹74 Cr
Consolidated Net Profit ₹84 Cr₹75 Cr₹71 Cr₹15 Cr₹68 Cr
Earnings Per Share (Rs)₹12.21₹8.00₹7.21₹6.80₹1.45
PAT Margin (%)13.9110.7110.5910.213.09
ROE(%)12.119.018.899.112.88
ROCE(%)17.4012.2912.1512.226.37
Total Debt/Equity(x)0.000.070.090.110.13

Key Financials

Market Cap : ₹ 5,627.0 Cr
Revenue (TTM) : ₹ 927.1 Cr
Net Profit(TTM) : ₹ 134.7 Cr
EPS (TTM) : ₹ 12.7
P/E (TTM) : 41.8

Industry Peers & Returns1W1M1Y
BLISS GVS PHARMA 1.2% 29.2% 240.7%
SUN PHARMACEUTICAL INDUSTRIES 1.4% 1.2% 13.8%
DIVIS LABORATORIES -0.5% -0.6% 4%
TORRENT PHARMACEUTICALS 2.1% 1.5% 42.2%
CIPLA 6.4% 1.6% -3.1%
DR REDDYS LABORATORIES 6.2% 1.6% 0.2%
MANKIND PHARMA 1.8% 1.8% 6.6%
LUPIN -0.4% 3.5% 22.5%
ZYDUS LIFESCIENCES 2.9% 2.1% 15.7%


BLISS GVS PHARMA Revenues
[BOM: 506197|NSE : BLISSGVS]

Y-o-Y

5.13 %

5 Yr CAGR

8.83 %

Years Revenues % Change
Mar2026 ₹810 Cr
5.13
Mar2025 ₹770 Cr
2.48
Mar2024 ₹752 Cr
0.55
Mar2023 ₹747 Cr
29.50
Mar2022 ₹577 Cr -


BLISS GVS PHARMA Operating Profit
[BOM: 506197|NSE : BLISSGVS]

Y-o-Y

-15.89 %

5 Yr CAGR

4.40 %

Years Operating Profit % Change
Mar2026 ₹127 Cr
-15.89
Mar2025 ₹151 Cr
28.38
Mar2024 ₹117 Cr
-0.86
Mar2023 ₹118 Cr
10.97
Mar2022 ₹107 Cr -

Operating Margins
Y-o-Y

-19.99 %

5 Yr CAGR

-4.07 %

Years Operating Margin% % Change
Mar2026 15.65%
-19.99
Mar2025 19.56%
25.30
Mar2024 15.61%
-1.39
Mar2023 15.83%
-14.34
Mar2022 18.48% -

BLISS GVS PHARMA Profit After Tax
[BOM: 506197|NSE : BLISSGVS]

Y-o-Y

11.72 %

5 Yr CAGR

5.33 %

Years Profit After Tax % Change
Mar2026 ₹84 Cr
11.72
Mar2025 ₹75 Cr
6.48
Mar2024 ₹71 Cr
371.14
Mar2023 ₹15 Cr
-78.04
Mar2022 ₹68 Cr -

PAT Margins
Y-o-Y

29.88 %

5 Yr CAGR

45.66 %

Years PAT Margin(%) % Change
Mar2026 13.91 %
29.88
Mar2025 10.71 %
1.13
Mar2024 10.59 %
3.72
Mar2023 10.21 %
230.42
Mar2022 3.09 % -

BLISS GVS PHARMA Earnings Per Share (EPS)
[BOM: 506197|NSE : BLISSGVS]

Y-o-Y

52.63 %

5 Yr CAGR

70.35 %

Years EPS % Change
Mar2026 ₹12
52.63
Mar2025 ₹8.00
10.96
Mar2024 ₹7.21
6.03
Mar2023 ₹6.80
368.97
Mar2022 ₹1.45 -

BLISS GVS PHARMA Return on Capital Employed (ROCE)
[BOM: 506197|NSE : BLISSGVS]

Y-o-Y

41.58 %

5 Yr CAGR

28.56 %

Years ROCE % Change
Mar2026 17.4%
41.58
Mar2025 12.29%
1.15
Mar2024 12.15%
-0.57
Mar2023 12.22%
91.84
Mar2022 6.37% -

BLISS GVS PHARMA Share Price vs Sensex

Current Share Price : ₹530.4
Current MarketCap: ₹ 5,627.0 Cr
Updated EOD on :Jun 29,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

1.2%

29.2%

240.7%

SENSEX

-0.1%

1%

-5.7%

BLISS GVS PHARMA related INDICES

BSE Indices1W1M1Y
BSE HEALTHCARE 2.5% 3.3% 14.7%
No NSE index found

You may also like the below Video Courses


FAQ about BLISS GVS PHARMA Financials


How the annual revenues of BLISS GVS PHARMA have changed ?

The Revenues of BLISS GVS PHARMA have increased by 5.13% YoY .

How the Earnings per Share (EPS) of BLISS GVS PHARMA have changed?

The Earnings Per Share (EPS) of BLISS GVS PHARMA has increased by 52.63 % YoY .